Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products / Point-of-care and ambulatory testing

SubmarketREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Point-of-care and ambulatory testing

Rapid diagnostic tests and compact analysers used in physician practices, urgent-care centres, emergency departments and alternative-care sites.

Market size
$18.5B
$18.5B ($13.0B–$24.0B) · 2025 · Bottom-up
Growth
+6.6%
$30.0B by 2032
Attractiveness
60 /100
for B2B sellers
Evidence
Low confidence
4 sources · Bottom-up
Level
Submarket
Segmented by
Customer type
Buyers
Physician practices, ambulatory and alternative-care sites
Buying centre
Medical directors, clinical staff, procurement, finance
Maturity
Growth
Structure
Fragmented
Buying triggers
  • Alternative-site testing build-out by urgent-care and primary-care chains [2]
  • New rapid test clearances and reader launches
  • Chronic-care monitoring reimbursement expansion
Pains
  • Clinicians need results during the patient visit, not days later
  • Low throughput per site limits scale economics
  • Fragmented procurement across thousands of small sites
  • Poor connectivity and data integration with practice systems
Scores (1–5)
Pain intensity3
Purchasing power2
Reachability3
Growth4
Growth drivers
  • MedTech moving beyond traditional care settings into ambulatory and alternative sites [2]
  • Rapid turnaround needs in urgent-care centres and emergency departments
  • Chronic disease monitoring shifting to physician-office settings
  • Kits leading product type mix in clinical diagnostics [1]
Headwinds
  • Fragmented, price-sensitive buyer base with low single-site volumes
  • Reimbursement variability for rapid tests outside clinical laboratories
  • Commoditisation of basic rapid tests compressing price
Trends
  • Compact analyser placement in physician practices and pharmacies
  • Connected/AI-enabled readers as a value-add layer [2]
  • Shift of routine monitoring out of central labs

Niches 4

Split by customer type.

Niche70/100

Physician practices: acute-care rapid testing

Independent and multi-site physician practices that buy rapid diagnostic tests to triage patients during the visit, support clinical decisions and avoid unnecessary referral or eme

—
Independent and multi-site physician practices
not sizedOpen
Niche80/100

Urgent-care centres: high-throughput rapid testing

Urgent-care operators that buy rapid tests and compact analysers to triage walk-in patients, rule out time-sensitive conditions and direct patients to the appropriate care pathway.

—
Urgent-care centres and urgent-care operators
not sizedOpen

How this was sized

$18.5B ($13.0B–$24.0B) · 2025 · Bottom-up

Bottom-up: global diagnostic tests market USD 118.6bn (2025) [3][4]. Kits led product type mix [1]; point-of-care kits and compact analysers estimated at ~15% of the global diagnostic tests market, giving ~USD 17.8bn, rounded to USD 18.5bn. Cross-check: North America is 40.0% of clinical diagnostics value [1] and alternative care settings are a stated growth vector [2]. Forecast scaled at the 6.60% market CAGR [3][4] to ~USD 30bn by 2032. Low confidence: no source isolates point-of-care revenue.

Alongside it in Diagnostics and laboratory products

// Sell into Point-of-care and ambulatory testing

AOS finds the biggest accounts in this submarket with a reason to talk now, maps their buying centre and prepares the outreach for your approval.